Evaluation of the absolute oral bioavailability and bioequivalence of erlotinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in a randomized, crossover study in healthy subjects (Q46555261)
Jump to navigation
Jump to search
scientific article published in March 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of the absolute oral bioavailability and bioequivalence of erlotinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in a randomized, crossover study in healthy subjects |
scientific article published in March 2006 |
Statements
1 reference
Evaluation of the absolute oral bioavailability and bioequivalence of erlotinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in a randomized, crossover study in healthy subjects (English)
1 reference
Paul Frohna
1 reference
Jianfeng Lu
1 reference
Steve Eppler
1 reference
Marta Hamilton
1 reference
Julie Wolf
1 reference
Ashok Rakhit
1 reference
Jie Ling
1 reference
Saraswati R Kenkare-Mitra
1 reference
Bert L Lum
1 reference
1 March 2006
1 reference
46
1 reference
3
1 reference
282-290
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference